Does Prime Medicine, Inc. (PRME) Have the Potential to Rally 133.64% as Wall Street Analysts Expect?

Shares of Prime Medicine, Inc. (PRME) have gained 18% over the past four weeks to close the last trading session at $6.42, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15 indicates a potential upside of 133.6%. They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with ...